Surmodics (SRDX) 10-Q2011 Q1 Quarterly report

Filed: 4 Feb 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Bad

New words: addressing, advisor, advisory, bank, branded, caution, commitment, conjunction, consummated, deliver, deployment, dermatology, disclaim, discovery, enhance, entitled, Euronext, experienced, explore, expressed, foregoing, fourth, heading, important, inability, Jaffray, Job, located, microparticle, negotiate, neurology, noncompliance, oncology, peripheral, phase, Piper, predictable, profitable, protein, qualified, Reauthorization, reduction, reformulated, relocated, Removed, speak, spending, technical, test, Unemployment, urology, variable

Removed: acceptance, acetonide, acquire, affiliated, alternative, AMD, analyzed, Apollo, area, attainment, attract, attribution, August, authoritative, back, behalf, billed, billing, broken, cardiovascular, carry, ceased, characterized, closing, collaborative, column, combination, combine, commence, comparable, consistency, consistent, consolidating, consolidation, contributor, cumulative, declining, dedicated, deferral, degeneration, diabetic, discount, discounting, DME, edema, Eden, Emergency, estimating, EU, expand, eye, fact, feasibility, focused, forma, format, frequent, gave, God, greater, guaranteed, harbor, headcount, immunoassay, implant, implemented, inaccurate, incomplete, indemnified, indirectly, integrate, intended, intravitreal, invoicing, itsin, Japan, joint, justified, launch, lead, LLC, macular, main, marketed, markup, matured, Merck, Minnesota, modified, nature, Nexeon, noted, notice, offered, offering, ongoing, oral, originating, ourin, ourpro, outcome, ownership, Paragon, partial, participate, personnel, Prairie, prepaid, pro, prospective, protect, public, ranged, ratanet, recognition, recognizing, reduced, reflected, reimbursement, relate, renewal, reportable, response, restructured, retinal, reversal, review, safe, satisfactory, satisfy, scientifically, secure, segment, sell, sensitive, serve, shift, shown, single, strictly, suitable, swap, terminate, terminated, terminating, terrorism, thein, titled, treatment, trend, triamcinolone, understand, unknown, vacated, variety, vary, viable, vitrodiagnostic, volatile, withholding, written

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

SRDX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of SurModics, Inc. (the “Company”) on Form 10-Q for the quarter ended December 31, 2010, as filed with the Securities and Exchange Commission (the “Report”), I, Philip D. Ankeny, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

	(1)		The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)		The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: February 4, 2011	Signature:	/s/ Philip D. Ankeny
		Philip D. Ankeny
		Senior Vice President and Chief Financial Officer